Skip to main content
Year archive

SHIELD THERAPEUTICS PLC — 2019 filings

All 41 regulatory filings released by SHIELD THERAPEUTICS PLC (STX) in 2019, sourced directly from the official regulator.

41 Filings
2019 Period
2019 filings (41)
Filing Released Lang
Eland Oil & Gas
Delisting Announcement
2019-12-12 English
Holding(s) in Company
Major Shareholding Notification
2019-11-29 English
QCA Corporate Governance Code
Regulatory Filings
2019-11-25 English
Hardman & Co Research: Shield Therapeutics (STX): More choice for clinicians and patients
Report Publication Announcement
2019-10-30 English
Positive results presented at UEG Week 2019
Regulatory Filings
2019-10-22 English
Investor Presentation
Investor Presentation
2019-09-26 English
Hardman & Co Research: Shield Therapeutics (STX): FDA approval ushers in a new era for Shield
Regulatory Filings
2019-09-02 English
Investor presentations
Report Publication Announcement
2019-08-29 English
Director/PDMR Shareholding
Director's Dealing
2019-08-15 English
Half-year Report
Interim / Quarterly Report H1 2019
2019-08-07 English
Hardman & Co Research: Shield Therapeutics (STX) FDA approval opens door to major US opportunity
Regulatory Filings
2019-08-05 English
Hardman & Co Research: Shield Therapeutics (STX) FDA approval opens door to major US opportunity
Regulatory Filings
2019-08-05 English
Hardman & Co Research: Shield Therapeutics (STX) FDA approval opens door to major US opportunity
Regulatory Filings
2019-08-05 English
Notice of Results
Report Publication Announcement
2019-07-31 English
Second Price Monitoring Extn
Regulatory Filings
2019-07-26 English
Price Monitoring Extension
Regulatory Filings
2019-07-26 English
FDA approves Feraccru® with a broad label
Regulatory Filings
2019-07-26 English
Additional Listing
Regulatory Filings
2019-07-02 English
Result of AGM
AGM Information
2019-06-13 English
Update on Legal Proceedings
Legal Proceedings Report
2019-06-03 English
Appointment of Joint Broker
Regulatory Filings
2019-05-08 English
Investor presentation
Regulatory Filings
2019-05-02 English
Additional Listing
Regulatory Filings
2019-05-01 English
2018 Annual Report and 2019 AGM Notice
AGM Information
2019-04-30 English
PDMR Acquisition of Shares
Director's Dealing
2019-04-26 English
Major extension to approval in Switzerland
Regulatory Filings
2019-04-24 English
Grant of share options
Remuneration Information
2019-04-17 English
PDMR Acquisition of Shares and Additional Listing
Regulatory Filings
2019-04-17 English
PDMR Acquisition of Shares
Director's Dealing
2019-04-17 English
Holding(s) in Company
Major Shareholding Notification
2019-04-11 English
Additional Listing
Share Issue/Capital Change
2019-04-08 English
Final Results
Earnings Release FY 2018
2019-04-03 English
Additional Listing
Declaration of Voting Results & Voting Rights Announcements
2019-04-01 English
Change of Adviser
Regulatory Filings
2019-04-01 English
Positive decision on Feraccru®'s process patent
Regulatory Filings
2019-03-14 English
Positive results for Feraccru® in AEGIS-H2H study
Earnings Release FY 2018
2019-03-04 English
Positive results of AEGIS-CKD study
Regulatory Filings
2019-01-29 English
Hardman & Co Research: Shield Therapeutics (STX): Cast-iron investment
Regulatory Filings
2019-01-28 English
Business and trading update
Earnings Release FY 2018
2019-01-24 English
Investor presentations
Regulatory Filings
2019-01-23 English
Appointment of Chairman
Regulatory Filings
2019-01-22 English